Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 19/20 | 0.58 |
| ▸ | OXTR | P30559 | 10/20 | 0.58 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8368994 | 0.83 | AVPR2 (0.61) | AVPR2OXTRAVPR1A | |
| Hydrochloric Acid SCHEMBL4828748 | 0.83 | AVPR2 (0.61) | AVPR2OXTRAVPR1A | |
| SCHEMBL1662737 | 0.80 | AVPR2 (0.73) | AVPR2OXTRAVPR1A | |
| SCHEMBL38725 | 0.78 | AVPR1A (0.47) | AVPR2OXTRAVPR1A | |
| Trifluoroacetic Acid SCHEMBL6202229 | 0.76 | AVPR2 (0.67) | AVPR2OXTRAVPR1A | |
| SCHEMBL38963 | 0.76 | AVPR2 (0.47) | AVPR2OXTRAVPR1A | |
| SCHEMBL5435288 | 0.76 | AVPR2 (0.88) | AVPR2OXTRAVPR1A | |
| SCHEMBL4835899 | 0.71 | AVPR2 (0.60) | AVPR2OXTR | |
| SCHEMBL6202773 | 0.70 | AVPR1A (0.55) | AVPR2OXTRAVPR1A | |
| SCHEMBL4835299 | 0.69 | AVPR1A (0.54) | AVPR2OXTRAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575853-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A FEEDING DISORDER WITH EARLY-ONSET IN A PATIENT | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011147889-A1 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A FEEDING DISORDER WITH EARLY-ONSET IN A PATIENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2011-12-01 | — | — | WO | disclosed |